Literature DB >> 7890486

Local action of the renin angiotensin system in the porcine ophthalmic circulation: effects of ACE-inhibitors and angiotensin receptor antagonists.

P Meyer1, J Flammer, T F Lüscher.   

Abstract

PURPOSE: The renin angiotensin system and endothelium-derived substances are important regulators of the microcirculation. The authors studied the roles of angiotensins (Ang), angiotensin converting enzyme (ACE)-inhibitors, and Ang II-receptor antagonists in the porcine ophthalmic circulation.
METHODS: Isolated porcine ciliary arteries were studied in myographs and the intact porcine eye in a perfusion system at 80 cm H2O perfusion pressure with Krebs-ringer bicarbonate solution (37 degrees C, 95% O2, 5% CO2).
RESULTS: ACE-inhibitors enalaprilat and benazepril (both 10(-5) M) did not change ciliary vascular tone nor flow of perfused porcine eyes. However, enalaprilat or benazepril enhanced the relaxation of ciliary arteries to bradykinin (P < 0.02). In the perfused porcine eye, enalaprilat (10(-5) M) augmented vasodilation to bradykinin (P < 0.02). The bradykinin antagonist Hoe 140 (3 x 10(-7) M) prevented the relaxation of ciliary arteries to bradykinin (P < 0.001), but not to acetylcholine. In perfused eyes, Hoe 140 reduced the vasodilation to bradykinin (P < 0.01). Ang II (10(-8) to 10(-6) M) evoked a contraction of ciliary arteries and was more potent than Ang I. Enalaprilat abolished the effect of Ang I. The AT1-receptor antagonist, valsartan (10(-9) to 10(-5) M; 30 minutes) inhibited the response of ciliary arteries to Ang II, whereas the AT2-receptor ligand CGP 42112 B (10(-7) to 10(-8) M) was ineffective. In the perfused porcine eye, valsartan restored the decrease in flow to Ang II.
CONCLUSIONS: Angiotensins play an important regulatory role in the porcine ophthalmic microcirculation through AT1-receptors. ACE-inhibitors prevents the effects of Ang 1 and augment endothelium-dependent relaxation to bradykinin, which releases nitric oxide through B2 receptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890486

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

Review 1.  Use of isolated ocular arteries in vitro to define the pathology of vascular changes in glaucoma.

Authors:  C H Buckley; P W Hadoke; C J O'Brien
Journal:  Br J Ophthalmol       Date:  1997-07       Impact factor: 4.638

2.  Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.

Authors:  Kazuyuki Hirooka; Fumio Shiraga
Journal:  Clin Ophthalmol       Date:  2007-09

Review 3.  Vascular protective effects of ACE inhibitors and calcium antagonists: theoretical basis for a combination therapy in hypertension and other cardiovascular diseases.

Authors:  T F Lüscher; R R Wenzel; P Moreau; H Takase
Journal:  Cardiovasc Drugs Ther       Date:  1995-08       Impact factor: 3.727

Review 4.  Energy Metabolism in the Inner Retina in Health and Glaucoma.

Authors:  Hanhan Liu; Verena Prokosch
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

5.  Evaluation of Systemic Renin and Angiotensin II Levels in Normal Tension Glaucoma.

Authors:  Soo Ji Jeon; Hyung Bin Hwang; Na Young Lee
Journal:  J Clin Med       Date:  2020-11-26       Impact factor: 4.241

6.  Losartan Treatment Protects Retinal Ganglion Cells and Alters Scleral Remodeling in Experimental Glaucoma.

Authors:  Harry A Quigley; Ian F Pitha; Derek S Welsbie; Cathy Nguyen; Matthew R Steinhart; Thao D Nguyen; Mary Ellen Pease; Ericka N Oglesby; Cynthia A Berlinicke; Katherine L Mitchell; Jessica Kim; Joan J Jefferys; Elizabeth C Kimball
Journal:  PLoS One       Date:  2015-10-27       Impact factor: 3.240

Review 7.  Ocular Blood Flow Autoregulation Mechanisms and Methods.

Authors:  Xue Luo; Yu-Meng Shen; Meng-Nan Jiang; Xiang-Feng Lou; Yin Shen
Journal:  J Ophthalmol       Date:  2015-10-21       Impact factor: 1.909

Review 8.  The discovery of the Flammer syndrome: a historical and personal perspective.

Authors:  Josef Flammer; Katarzyna Konieczka
Journal:  EPMA J       Date:  2017-05-22       Impact factor: 6.543

9.  Bioenergetic shift and actin cytoskeleton remodelling as acute vascular adaptive mechanisms to angiotensin II in murine retina and ophthalmic artery.

Authors:  Natarajan Perumal; Lars Straßburger; David P Herzog; Marianne B Müller; Norbert Pfeiffer; Franz H Grus; Caroline Manicam
Journal:  Redox Biol       Date:  2020-05-29       Impact factor: 11.799

10.  Angiotensin receptor blocker-induced bilateral ciliochoroidal effusion.

Authors:  Kanika Aggarwal; Aniruddha Agarwal; Ashok Gupta; Reeti Saini; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2020-06       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.